Akebia Therapeutics (AKBA) Net Margin (2013 - 2026)
Akebia Therapeutics (AKBA) posted Net Margin of -18.13% for Q2 2026, down 18.53 percentage points from 0.40% a year earlier and down 1.22 percentage points from the prior quarter.
Powered by 
Analysis
Akebia Therapeutics (AKBA) Net Margin (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Net Margin at Akebia Therapeutics was -13.54%, up 4.37 percentage points year-over-year; for FY2025, it came in at -2.26%, up 41.07 percentage points from FY2024.
- Annual Net Margin shows a five-year change of +128.35 percentage points (FY2020 to FY2025).
- In prior years, Akebia Therapeutics' Net Margin was -43.33% in FY2024 (-16.65 pp), -26.68% in FY2023 (+5.54 pp), -32.22% in FY2022 (+101.03 pp) and -133.25% in FY2021 (-2.64 pp).
- Quarterly Net Margin has run from a low of -122.13% in Q3 2021 to a high of 23.30% in Q2 2022 over five years.
- On a year-over-year basis, Net Margin increased in four of the last eight quarters, with an average year-over-year change of +6.60 percentage points.
- The strongest year-over-year quarter for Net Margin in the past five years was Q2 2022, with a gain of 180.24 percentage points; the weakest was Q4 2024, with a drop of 50.14 percentage points.
- According to Business Quant data, Net Margin for the three prior quarters was -16.91% (Q1 2026), -21.25% (Q4 2025) and 0.92% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 19.55% |
| 10 | Akebia Therapeutics | 149.86 Mn | -512.48 Mn | 30.54 Mn | -38.90% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -38.90% |
| Jun 30, 2026 | -18.13% |
| Mar 31, 2026 | -16.91% |
| Dec 31, 2025 | -21.25% |
| Sep 30, 2025 | 0.92% |
| Jun 30, 2025 | 0.40% |
| Mar 31, 2025 | 10.66% |
| Dec 31, 2024 | -49.04% |
| Sep 30, 2024 | -53.54% |
| Jun 30, 2024 | -19.66% |
| Mar 31, 2024 | -55.16% |
| Dec 31, 2023 | 1.09% |
| Sep 30, 2023 | -34.46% |
| Jun 30, 2023 | -19.82% |
| Mar 31, 2023 | -67.18% |
| Dec 31, 2022 | -10.88% |
| Sep 30, 2022 | -111.05% |
| Jun 30, 2022 | 23.30% |
| Mar 31, 2022 | -102.93% |
| Dec 31, 2021 | -121.13% |
API Access
Akebia Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=AKBA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "AKBA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=AKBA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();